A Mobile Health Intervention in Pulmonary Arterial Hypertension

NACompletedINTERVENTIONAL
Enrollment

49

Participants

Timeline

Start Date

August 2, 2017

Primary Completion Date

April 24, 2020

Study Completion Date

April 24, 2020

Conditions
Pulmonary Arterial HypertensionIdiopathic Pulmonary Arterial HypertensionHeritable Pulmonary Arterial HypertensionAssociated Pulmonary Arterial Hypertension
Interventions
DEVICE

Smartphone Text Messaging

A HIPPA compliant text messaging platform is linked to the Fitbit Application Program Interface. Real time activity data will be transmitted from the subject's smartphone to our mHealth platform via cellular network. Subjects will receive 3 texts/day in sync with their preferred morning, lunch, and evening leisure schedule (defined at enrollment). These texts will use personal, disease-specific, and provider information to deliver 2 types of messages customized to the current step count and sent in equal proportion. Messages are designed to facilitate self-awareness, reinforce step targets, and link physical activity with a reward or memorable cue.

DEVICE

Fitbit Charge HR

The Fitbit Charge HR tri-axial accelerometer will be used to continuously gather data on physical activity, heart rate, and sleep. This device provides feedback in units of activity (steps, stairs climbed, activity time, and exercise time) and heart rate (per second when active, per 5 seconds when inactive). It has been validated against research devices in free-living conditions and is relatively inexpensive.

Trial Locations (1)

37232

Vanderbilt University Medical Center, Nashville

All Listed Sponsors
collaborator

Johns Hopkins University

OTHER

lead

Vanderbilt University Medical Center

OTHER

NCT03069716 - A Mobile Health Intervention in Pulmonary Arterial Hypertension | Biotech Hunter | Biotech Hunter